Article
Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 Carbapenemase in Qatar
23 Feb 2016
Abstract excerpt
The objective of our study was to describe the molecular support of carbapenem resistance from randomly selected clinical isolates of multidrug-resistant (MDR) Acinetobacter baumannii as a pilot study from the Hamad Medical Corporation (HMC), Qatar. Results of our report will be used to study carbapenemases using molecular techniques in all isolated MDR A. baumannii. Forty-eight MDR A. baumannii were randomly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
